<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">DIPHENOXYLATE HYDROCHLORIDE WITH ATROPINE SULFATE <img border="0" src="../images/pr.gif"/></span><br/>(dye-fen-ox'i-late)<br/><span class="topboxtradename">Diphenatol, </span><span class="topboxtradename">Lofene, </span><span class="topboxtradename">Lomanate, </span><span class="topboxtradename">Lomotil, </span><span class="topboxtradename">Lonox, </span><span class="topboxtradename">Lo-Trol, </span><span class="topboxtradename">Low-Quel, </span><span class="topboxtradename">Nor-Mil<br/></span><b>Classifications:</b> <span class="classification">gastrointestinal agent</span>; <span class="classification">antidiarrheal</span><br/><b>Pregnancy Category: </b>C<br/><b>Controlled Substance: </b>Schedule V<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>2.5 mg tablets; 2.5 mg/5 mL liquid</p>
<h1><a name="action">Actions</a></h1>
<p>Diphenoxylate is a synthetic narcotic structurally related to meperidine. Commercially available only with atropine sulfate,
         added in subtherapeutic doses to discourage deliberate overdosage.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Has little or no analgesic activity or risk of dependence, except in high doses. Inhibits mucosal receptors responsible for
         peristaltic reflex, thereby reducing GI motility.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Adjunct in symptomatic management of diarrhea.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to diphenoxylate or atropine; severe dehydration or electrolyte imbalance, advanced liver disease, obstructive
         jaundice, diarrhea caused by pseudomembranous enterocolitis associated with use of broad-spectrum antibiotics; diarrhea associated
         with organisms that penetrate intestinal mucosa; diarrhea induced by poisons until toxic material is eliminated from GI tract;
         glaucoma; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Advanced hepatic disease, abnormal liver function tests; renal function impairment, patients receiving addicting drugs, addiction-prone
         individuals or those whose history suggests drug abuse; ulcerative colitis; young children (particularly patients with Down
         syndrome).
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Diarrhea</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 12 tablets or 12 teaspoons full (5 mL) 34 times/d (each tablet or 5 mL contains 2.5 mg diphenoxylate HCl
               and 0.025 mg atropine sulfate)<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> <i>212 y</i>, 0.30.4 mg/kg/d of liquid in divided doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Crush tablet if necessary and give with fluid of patient's choice.</li>
<li>Reduce dosage as soon as initial control of symptoms occurs.</li>
<li>Withhold drug in presence of severe dehydration or electrolyte imbalance until appropriate corrective therapy has been initiated.</li>
<li> 					Note: Treatment is generally continued for 2436 h before it is considered ineffective. 				</li>
<li>Store in tightly covered, light-resistant container, preferably 15°30° C (59°86° F), unless
            otherwise directed by manufacturer.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Hypersensitivity (pruritus, angioneurotic edema, giant urticaria, rash). <span class="typehead">CNS:</span> Headache, sedation, drowsiness, dizziness, lethargy, numbness of extremities; restlessness, euphoria, mental depression, weakness,
      general malaise. <span class="typehead">CV:</span> Flushing, palpitation, tachycardia. <span class="typehead">Special Senses:</span> Nystagmus, mydriasis, blurred vision, miosis (toxicity). <span class="typehead">GI:</span> Nausea, vomiting, anorexia, dry mouth, abdominal discomfort or distension, paralytic ileus, toxic megacolon. <span class="typehead">Other:</span> Urinary retention, swelling of gums. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <span class="classification">mao inhibitors</span> may precipitate hypertensive crisis; <b>alcohol</b> and other <span class="classification">cns depressants</span> may enhance CNS effects; also see <b>atropine.</b>
<h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 4560 min. <span class="typehead">Peak:</span> 2 h. <span class="typehead">Duration:</span> 34 h. <span class="typehead">Distribution:</span> Distributed into breast milk. <span class="typehead">Metabolism:</span> Rapidly metabolized to active and inactive metabolites in liver. <span class="typehead">Elimination:</span> Excreted slowly through bile into feces; small amount excreted in urine. <span class="typehead">Half-Life:</span> 4.4 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Assess GI function; report abdominal distention and signs of decreased peristalsis.</li>
<li>Monitor for S&amp;S of dehydration (see Appendix F). It is essential to monitor young children closely; dehydration occurs more
            rapidly in this age group and may influence variability of response to diphenoxylate and predispose patient to delayed toxic
            effects.
         </li>
<li>Monitor frequency and consistency of stools.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take medication only as directed by physician.</li>
<li>Notify physician if diarrhea persists or if fever, bloody stools, palpitation, or other adverse reactions occur.</li>
<li>Do not drive or engage in other potentially hazardous activities until response to drug is known.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>